Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

AVTOZMA 162 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/AVTOZMA 162 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA

Approved

STANDARD

AVTOZMA 162 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA

Celltrion Healthcare Hungary Kft.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Mar 24, 2025
Approval ID: d7f466e6a768039a
Company: Celltrion Healthcare Hungary Kft.
Type: Standard

Approval Details

Approval Id: d7f466e6a768039a
Drug Cima Aemps Name: AVTOZMA 162 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
Register Number: 1241896007
Holder Company Name: Celltrion Healthcare Hungary Kft.
Marketing Company Name: Celltrion Farmacéutica (España) S.L.
Holder Company Detail Path: /organization/518802646099655f/celltrion-healthcare-hungary-kft
Authorization Date: 2025-03-24
Dosage Form: SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA
Dose: 162 mg
Route Of Administration: VÍA SUBCUTÁNEA
Prescription Type: Diagnóstico Hospitalario
Commercialized: No
Company Name: Celltrion Healthcare Hungary Kft.
Company Detail Path: /organization/518802646099655f/celltrion-healthcare-hungary-kft

Company Information

Pharmaceutical Company Name: Celltrion Healthcare Hungary Kft
Country Name: Hungary

Active Ingredients

TOCILIZUMAB

162 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 24, 2025

Approval ID

d7f466e6a768039a

Type

Standard

Back to CIMA-AEMPS Approvals